Kristie Batten chatted with mining bigwigs Bill Beament and Simon Lawson on Trump's impact on miners, gold M&A and more.

Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...

President-elect Donald Trump’s return to the White House might favourably impact the psychedelics sector with ASX stocks in ...

China has escalated a trade war with the US, suspending gallium, germanium and antimony exports. That's another tailwind for ...

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing bonanza results at the Muckanippie project from ...

Retail investors can access private tech via two ASX stocks with Scalare providing support and Bailador targeting returns.

Argonaut's Hayden Bairstow predicts more Australian gold M&A could be on the horizon, with mergers likely for single asset ...

ASX rebounds slightly after weak GDP data as RBA rate cut talks grow, while Rio Tinto and Sumitomo strike a $615m copper deal.

A new government initiative will see a mandatory SMS Sender ID Register implemented by the Australian Communications and ...

Pro Medicus founders Dr Sam Hupert and Anthony Hall have lightened their holdings, but they still account for close to half ...

Gold and copper remain key pillars of Victor Smorgon Group's investing strategy, with gold miners "printing cash" the target.